BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25528475)

  • 21. NDRG1 overexpressing gliomas are characterized by reduced tumor vascularization and resistance to antiangiogenic treatment.
    Broggini T; Wüstner M; Harms C; Stange L; Blaes J; Thomé C; Harms U; Mueller S; Weiler M; Wick W; Vajkoczy P; Czabanka M
    Cancer Lett; 2016 Oct; 380(2):568-576. PubMed ID: 26297987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sunitinib impedes brain tumor progression and reduces tumor-induced neurodegeneration in the microenvironment.
    Hatipoglu G; Hock SW; Weiss R; Fan Z; Sehm T; Ghoochani A; Buchfelder M; Savaskan NE; Eyüpoglu IY
    Cancer Sci; 2015 Feb; 106(2):160-70. PubMed ID: 25458015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The novel immunotherapeutic molecule T11TS modulates glioma-induced changes of key components of the immunological synapse in favor of T cell activation and glioma abrogation.
    Chaudhuri S; Singh MK; Bhattacharya D; Acharya S; Chatterjee S; Kumar P; Bhattacharjee P; Basu AK; Sa G; Das T; Ghosh TK; Chaudhuri S
    J Neurooncol; 2014 Oct; 120(1):19-31. PubMed ID: 25026997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T11TS/S-LFA3 induces apoptosis of the brain tumor cells: a new approach to characterise the apoptosis associated genetic changes by arbitrarily primed-PCR.
    Mukherjee J; Ghosh A; Sarkar S; Mazumdar M; Sarkar P; Duttagupta AK; Chaudhuri S
    Cancer Lett; 2005 May; 222(1):23-38. PubMed ID: 15837538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quercetin disrupts tyrosine-phosphorylated phosphatidylinositol 3-kinase and myeloid differentiation factor-88 association, and inhibits MAPK/AP-1 and IKK/NF-κB-induced inflammatory mediators production in RAW 264.7 cells.
    Endale M; Park SC; Kim S; Kim SH; Yang Y; Cho JY; Rhee MH
    Immunobiology; 2013 Dec; 218(12):1452-67. PubMed ID: 23735482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancement of anti-tumor activity by low-dose combination of the recombinant urokinase kringle domain and celecoxib in a glioma model.
    Kim CK; Joe YA; Lee SK; Kim EK; O E; Kim HK; Oh BJ; Hong SH; Hong YK
    Cancer Lett; 2010 Feb; 288(2):251-60. PubMed ID: 19664879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiangiogenic therapy in brain tumors.
    Lakka SS; Rao JS
    Expert Rev Neurother; 2008 Oct; 8(10):1457-73. PubMed ID: 18928341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Re: angiogenesis and antiangiogenic therapy for malignant gliomas.
    Kepes JJ
    Brain Tumor Pathol; 2005; 22(1):51. PubMed ID: 18095105
    [No Abstract]   [Full Text] [Related]  

  • 29. Inhibition of NF-κB activation is associated with anti-inflammatory and anti-apoptotic effects of Ginkgolide B in a mouse model of cerebral ischemia/reperfusion injury.
    Gu JH; Ge JB; Li M; Wu F; Zhang W; Qin ZH
    Eur J Pharm Sci; 2012 Nov; 47(4):652-60. PubMed ID: 22850444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 1,3-Diphenylpropenone ameliorates TNBS-induced rat colitis through suppression of NF-κB activation and IL-8 induction.
    Park SY; Ku SK; Lee ES; Kim JA
    Chem Biol Interact; 2012 Mar; 196(1-2):39-49. PubMed ID: 22410118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kallistatin, a novel anti-angiogenesis agent, inhibits angiogenesis via inhibition of the NF-κB signaling pathway.
    Huang KF; Huang XP; Xiao GQ; Yang HY; Lin JS; Diao Y
    Biomed Pharmacother; 2014 May; 68(4):455-61. PubMed ID: 24721321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of G1 arrest in glioma cells by T11TS is associated with upregulation of Cip1/Kip1 and concurrent downregulation of cyclin D (1 and 3).
    Acharya S; Chatterjee S; Kumar P; Bhattacharjee M; Chaudhuri S; Chaudhuri S
    Anticancer Drugs; 2010 Jan; 21(1):53-64. PubMed ID: 19829098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pro- and Antiangiogenic Factors in Gliomas: Implications for Novel Therapeutic Possibilities.
    Groblewska M; Mroczko B
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34200145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PPARγ activation by baicalin suppresses NF-κB-mediated inflammation in aged rat kidney.
    Lim HA; Lee EK; Kim JM; Park MH; Kim DH; Choi YJ; Ha YM; Yoon JH; Choi JS; Yu BP; Chung HY
    Biogerontology; 2012 Apr; 13(2):133-45. PubMed ID: 22033706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neoechinulin A suppresses amyloid-β oligomer-induced microglia activation and thereby protects PC-12 cells from inflammation-mediated toxicity.
    Dewapriya P; Li YX; Himaya SW; Pangestuti R; Kim SK
    Neurotoxicology; 2013 Mar; 35():30-40. PubMed ID: 23261590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The anti-inflammation effect of baicalin on experimental colitis through inhibiting TLR4/NF-κB pathway activation.
    Cui L; Feng L; Zhang ZH; Jia XB
    Int Immunopharmacol; 2014 Nov; 23(1):294-303. PubMed ID: 25239813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ampelopsin attenuates lipopolysaccharide-induced inflammatory response through the inhibition of the NF-κB and JAK2/STAT3 signaling pathways in microglia.
    Weng L; Zhang H; Li X; Zhan H; Chen F; Han L; Xu Y; Cao X
    Int Immunopharmacol; 2017 Mar; 44():1-8. PubMed ID: 27998743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Flavonol-rich RVHxR from Rhus verniciflua Stokes and its major compound fisetin inhibits inflammation-related cytokines and angiogenic factor in rheumatoid arthritic fibroblast-like synovial cells and in vivo models.
    Lee JD; Huh JE; Jeon G; Yang HR; Woo HS; Choi DY; Park DS
    Int Immunopharmacol; 2009 Mar; 9(3):268-76. PubMed ID: 19111632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anticancer therapies combining antiangiogenic and tumor cell cytotoxic effects reduce the tumor stem-like cell fraction in glioma xenograft tumors.
    Folkins C; Man S; Xu P; Shaked Y; Hicklin DJ; Kerbel RS
    Cancer Res; 2007 Apr; 67(8):3560-4. PubMed ID: 17440065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiangiogenic drugs synergize with a membrane macrophage colony-stimulating factor-based tumor vaccine to therapeutically treat rats with an established malignant intracranial glioma.
    Jeffes EW; Zhang JG; Hoa N; Petkar A; Delgado C; Chong S; Obenaus A; Sanchez R; Khalaghizadeh S; Khomenko T; Knight BA; Alipanah R; Nguyen TV; Shah C; Vohra S; Zhuang JL; Liu J; Wepsic HT; Jadus MR
    J Immunol; 2005 Mar; 174(5):2533-43. PubMed ID: 15728459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.